Invitrogen, Agilent Technologies Settle Multiple Patent Litigations

Invitrogen Corporation (IVGN) and Agilent Technologies have jointly announced a confidential settlement of multiple patent litigations pending between the two companies. The settlement resolves three patent infringement lawsuits between Invitrogen and Stratagene Inc. Agilent acquired Stratagene in 2007.

Source: Agilent